CHORD THERAPEUTICS
Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. The company is advancing its lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG). The company was founded in 2014 and based in Geneva, Switzerland.
CHORD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.chordtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
16 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS AWS Global Accelerator Webflow
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omega Funds
Omega Funds investment in Series A - Chord Therapeutics
Eclosion SA
Eclosion SA investment in Seed Round - Chord Therapeutics
Official Site Inspections
http://www.chordtherapeutics.com
Unable to get host informations!!!
